UBS’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$15.6M Buy
220,900
+202,200
+1,081% +$14.4M 0.01% 1119
2014
Q2
$1.3M Sell
18,700
-49,300
-73% -$3.47M ﹤0.01% 3309
2014
Q1
$5.11M Sell
68,000
-127,700
-65% -$9.56M ﹤0.01% 1855
2013
Q4
$13.7M Sell
195,700
-218,400
-53% -$14.3M 0.01% 1046
2013
Q3
$25.6M Buy
414,100
+208,900
+102% +$13.5M 0.03% 602
2013
Q2
$12.7M Buy
+205,200
New +$12.4M 0.02% 909

Other funds holding ESRX

UBS's ESRX Position: Q3 2014 in Review

UBS reduced its Express Scripts Holding Company (ESRX) stake by 6.3% in Q3 2014, selling an estimated $14.2M and leaving 2,942,077 shares worth $208M. The position accounts for 0.15% of the portfolio, ranked #147.

UBS first reported a position in ESRX in Q2 2013 and has held it in 6 quarters since. The position peaked at $238M in Q1 2014. 1,121 funds tracked by Wall St. Rank hold ESRX as of Q3 2014.

  • UBS held 2,942,077 shares of Express Scripts Holding Company worth $208M as of Q3 2014.
  • UBS sold 199,235 Express Scripts Holding Company shares in Q3 2014, an estimated $14.2M.
  • Express Scripts Holding Company made up 0.15% of UBS's portfolio in Q3 2014, its #147 holding.
  • UBS first reported a position in Express Scripts Holding Company in Q2 2013 and has held it in 6 quarters since.
  • UBS's Express Scripts Holding Company position peaked at $238M in Q1 2014.
  • 1,121 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.